Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

P1.082. Neoadjuvant Chemoradiotherapy-to-Surgery Interval and Survival Stratified by Pathological Response in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is the standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, the optimal interval between nCRT completion and surgery remains undetermined, particularly rega...

Xu Huang, Fangyi Liu, Han Tang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.